A Study of Aortic Valve Gradient Severity in Patients with Atrial Fibrillation

Overview

About this study

The purpose of this study is to examine if the measurements that we make by current standards for patients with both aortic stenosis (narrowed aortic valve) and atrial fibrillation underestimate severity of aortic stenosis and if that has any effect on timing of aortic valve surgery

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients (≥18 years of age) with previously diagnosed or newly diagnosed aortic valve stenosis and atrial fibrillation.

Exclusion Criteria: 

  • Patients <18 years of age
  • Prisoners
  • Patients who refuse participation in the study.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Vuyisile Nkomo, M.D., M.P.H.

Open for enrollment

Contact information:

Vuyisile Nkomo M.D., M.P.H.

(507)284-9325

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20304393

Mayo Clinic Footer